Among women of child-bearing potential, a study shows less prenatal exposure to phentermine-topiramate — a product that requires a Risk Evaluation and Mitigation Strategy (REMS)
Self-reported physical function improves after an intervention with weight-lowering pharmacotherapy, according to results of a systematic review and meta-analysis. “However, effects were modest and lower
The use of new-generation antiobesity medications in older adults presents “challenges and uncertainty” to the Medicare Part D program, Perspective authors write: “The burden of
Advances in the understanding and management of obesity and overweight are summarized based on discussions of an expert panel convened last week by the American
Compared with lifestyle intervention alone in adolescents with obesity, semaglutide 2.4 mg plus lifestyle intervention significantly reduced BMI at week 68 in the phase 3a
The challenges of supporting activities and behaviors to address obesity by people in their daily lives are explored in 2 studies and an editorial. An
Remote filling of prescriptions by CVS Health is examined in a Wall Street Journal report. The company touts the practice as a way of addressing
Used with behavioral weight loss therapy (BWL), naltrexone-bupropion was associated with significant improvements in binge-eating disorder, researchers report. Participants in the study had comorbid obesity,
In the Semaglutide Treatment Effect in People with obesity (STEP) 1, 3, and 4 trials, participants with baseline prediabetes had improved glucose metabolism and a
Adults with overweight and obesity who do not lose enough weight on lifestyle interventions alone should receive long-term pharmacotherapy with antiobesity medications (AOM) such as